from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3775/lipE

LFCtreatmentdescriptionclass of inhibitor

0.758

Amikacinug/mL Amikacintranslation

-0.844

Cap5-10ug/mL Capreomycintranslation

-0.850

Rox10-50 ug/mL Roxithromycintranslation

0.677

SM2-5 ug/mL Streptomycintranslation

0.910

Tet5-10 ug/mL Tetracyclinetranslation

0.370

Rif0.2-5ug/mL Rifampicintranscription

0.420

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.173

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.007

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.420

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.114

Clofazimine10-13 ug/mL Clofaziminerespiration

0.419

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.686

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.252

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.503

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.203

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.207

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.090

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.854

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.486

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.307

KCN5-20 ug/mL Potassium cyaniderespiration

1.163

NaN30.2-2 mM Sodium aziderespiration

-0.296

Nigericin50 uM Nigericinrespiration

-0.096

TRC10-150 ug/mL Triclosanrespiration

-1.805

TRZ10-25 ug/mL Thioridazinerespiration

-2.602

Valinomycin0.5-10 uM Valinomycinrespiration

-1.761

ZnSO42 mM ZnSO4respiration

-0.369

menadione6-10 ug/mL Menadionerespiration

-0.112

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.373

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.197

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.510

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.340

NRP_1Non-replicating persistence stage 1dosRassociated

0.672

Amp0.2mg/mL AmpicillincellWall

0.518

Cephalexin20-100 ug/mL CephalexincellWall

-0.005

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.090

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.395

EMB10-20 ug/mL EthambutolcellWall

0.394

Eta12-40 ug/mL EthionamidecellWall

0.320

INH0.2-0.4 ug/mL IsoniazidcellWall

0.321

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.236

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.114

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.875

BZA0.12 mg/mL BenzamidearomaticAmides

0.610

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.506

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.315

H2O24 mM hydrogen peroxideDNAdamaging

0.638

Levo10 ug/mL LevofloxacinDNAdamaging

0.309

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.386

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.013

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.106

UVUV-irradiationDNAdamaging

-1.257

ARP41-4 ug/mL Antitubercular compound ARP4?

0.214

Antimycin12.5-50 ug/mL Antimycin A?

0.146

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.047

PA_110-50 ug/mL Antitubercular compound PA-1?

0.094

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.650

PA8240.2-2 ug/mL PA-824?

0.246

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.287

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.251

Verapamil50 uM Verapamil?

0.152

mercaptoethanol2 mM 2-Mercaptoethanol?

0.033

methoxatin10-20 ug/mL Methoxatin?